Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Ministry of AYUSH develops drugs for Dengue, Cancer

      Ministry of AYUSH develops drugs for Dengue, Cancer

      Ruby Khatun Khatun11 Aug 2017 9:18 AM IST
      New Delhi: The Ministry of Ayurveda, Unani, Siddha and Homeopathy (AYUSH) has developed drugs for Dengue, cancer, migrain and asthma, the Rajya Sabha...
      Zydus Cadila gets USFDA nod to market hypertension drug

      Zydus Cadila gets USFDA nod to market hypertension drug

      Ruby Khatun Khatun11 Aug 2017 9:16 AM IST
      New Delhi: Drug firm Zydus Cadila has received the US health regulator's nod to market Diltiazem Hydrochloride capsules, used to treat high blood...
      Lupin receives USFDA nod for cholesterol drug

      Lupin receives USFDA nod for cholesterol drug

      Ruby Khatun Khatun11 Aug 2017 9:15 AM IST
      New Delhi: Drug firm Lupin has received approval from the US health regulator to market Pitavastatin tablets used for lowering cholesterol.In a BSE...
      FDA to expand public education campaign to focus on prevention of youth e-cigarette use

      FDA to expand public education campaign to focus on prevention of youth e-cigarette use

      Ruby Khatun Khatun11 Aug 2017 9:15 AM IST
      The U.S. Food and Drug Administration (FDA) announced it would pursue a strategic, new public health education campaign aimed at discouraging the use...
      Roche unloads some rights to drug hopeful after asthma trial disappointment

      Roche unloads some rights to drug hopeful after asthma trial disappointment

      Ruby Khatun Khatun11 Aug 2017 9:14 AM IST
      ZURICH: Roche is offloading some rights to what was once one of its top drug prospects, lebrikizumab, for payments which could total more than $1...
      Bristol-Myers Squibb to buy IFM Therapeutics to strengthen cancer pipeline

      Bristol-Myers Squibb to buy IFM Therapeutics to strengthen cancer pipeline

      Ruby Khatun Khatun11 Aug 2017 9:14 AM IST
      Bristol-Myers Squibb Co said it would buy privately held IFM Therapeutics for an upfront payment of $300 million, as the drugmaker looks to bolster...
      Margin on revision knee surgery implants as high as 277 percent: NPPA

      Margin on revision knee surgery implants as high as 277 percent: NPPA

      Ruby Khatun Khatun10 Aug 2017 11:30 AM IST
      New Delhi: Drug price regulator NPPA said it has found average trade margins on various knee implants used in revision surgery to be as high as 277...
      Pharma, medical devices should be under one ministry: Mansukh L Mandaviya

      Pharma, medical devices should be under one ministry: Mansukh L Mandaviya

      Ruby Khatun Khatun10 Aug 2017 10:00 AM IST
      New Delhi: The Department of Pharmaceuticals (DoP) feels that subjects and regulatory bodies related to pharmaceuticals and medical devices should...
      Mylan Launches Avonza in India for HIV

      Mylan Launches Avonza in India for HIV

      Ruby Khatun Khatun10 Aug 2017 10:00 AM IST
      HERTFORDSHIRE, England and PITTSBURGH: Mylan Pharmaceuticals Private Limited, a subsidiary of Mylan N.V., a leading global pharmaceutical company, has...
      FDA approves Mavyret for Hepatitis C

      FDA approves Mavyret for Hepatitis C

      Ruby Khatun Khatun10 Aug 2017 9:45 AM IST
      The U.S. Food and Drug Administration (FDA) approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV)...
      Zydus Cadila gets USFDA nod to market HIV drug

      Zydus Cadila gets USFDA nod to market HIV drug

      Ruby Khatun Khatun10 Aug 2017 9:30 AM IST
      New Delhi: Drug firm Zydus Cadila on Tuesday said it has received the tentative approval from the US health regulator to market Abacavir and...
      The Ministry of AYUSH grants Rs 3.5 crore to conduct research in Ayurveda and other alternative medicines

      The Ministry of AYUSH grants Rs 3.5 crore to conduct research in Ayurveda and other alternative medicines

      Ruby Khatun Khatun10 Aug 2017 9:20 AM IST
      The Interdisciplinary School of Health Sciences (ISHS) at Savitribai Phule Pune University, which offers post graduate courses in public health,...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok